消息
×
loading..
中文版 | English

在结果中检索

KMS

浏览/检索结果: 共4条，第1-4条 帮助

  只显示已认领条目
已选(0)清除 条数/页：   排序方式：
SAF-189s, a potent new-generation ROS1 inhibitor, is active against crizotinib-resistant ROS1 mutant-driven tumors 期刊论文
ACTA PHARMACOLOGICA SINICA, 2021
作者:  Xia, Zong-jun;  Ji, Yin-chun;  Sun, De-qiao;  Peng, Xia;  Gao, Ying-lei
Adobe PDF(2184Kb)  |  收藏  |  浏览/下载：324/4  |  提交时间：2020/11/02
Farnesoid X Receptor Constructs an Immunosuppressive Microenvironment and Sensitizes (FXRPD)-P-high-L1(low) NSCLC to Anti-PD-1 Immunotherapy 期刊论文
CANCER IMMUNOLOGY RESEARCH, 2019, 卷号: 7, 期号: 6, 页码: 990-1000
作者:  You, Wenjie;  Li, Lijun;  Sun, Deqiao;  Liu, Xueqing;  Xia, Zongjun
Adobe PDF(12847Kb)  |  收藏  |  浏览/下载：486/10  |  提交时间：2019/07/01
Discovery of 2,4-diarylaminopyrimidines bearing a resorcinol motif as novel ALK inhibitors to overcome the G1202R resistant mutation 期刊论文
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 卷号: 144, 页码: 386-397
作者:  Geng, Kaijun;  Xia, Zongjun;  Ji, Yinchun;  Zhang, Ruisi (Ruthy);  Sun, Deqiao
Adobe PDF(1645Kb)  |  收藏  |  浏览/下载：494/1  |  提交时间：2018/04/11
An orally available tyrosine kinase ALK and RET dual inhibitor bearing the tetracyclic benzo[b]carbazolone core 期刊论文
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 卷号: 118, 页码: 244-249
作者:  Song, Zilan;  Xia, Zongjun;  Ji, Yinchun;  Xing, Li;  Gao, Yinglei
Adobe PDF(968Kb)  |  收藏  |  浏览/下载：503/1  |  提交时间：2017/07/04
  • 首页
  • 上一页
  • 1
  • 下一页
  • 末页